Common Contracts
4 similar Consulting Agreement contracts by Morphic Holding, Inc.
MORPHIC HOLDING, INC. CONSULTING AGREEMENT (Timothy A. Springer, Ph.D.)Consulting Agreement • February 27th, 2020 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (this “Agreement”) is made effective as of December 5, 2019. In consideration for retaining Timothy A. Springer, Ph.D. (“Consultant”) by Morphic Holding, Inc., (the “Company”), a Delaware corporation. For good and valuable consideration, the parties hereby agree as follows:
CONSULTING AGREEMENT (Timothy A. Springer, Ph.D.)Consulting Agreement • June 14th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (this “Agreement”) is made effective as of June 1, 2015. In consideration for retaining Timothy A. Springer, Ph.D. (“Consultant”) by Morphic Rock Holding, LLC, f/k/a Integrin Rock, LLC (the “Company”), a Delaware limited liability company. For good and valuable consideration, the parties hereby agree as follows:
CONSULTING AGREEMENT (Timothy A. Springer, Ph.D.)Consulting Agreement • May 30th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (this “Agreement”) is made effective as of June 1, 2015. In consideration for retaining Timothy A. Springer, Ph.D. (“Consultant”) by Morphic Rock Holding, LLC, f/k/a Integrin Rock, LLC (the “Company”), a Delaware limited liability company. For good and valuable consideration, the parties hereby agree as follows:
CONSULTING AGREEMENT (Timothy A. Springer, Ph.D.)Consulting Agreement • April 12th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (this “Agreement”) is made effective as of June 1, 2015. In consideration for retaining Timothy A. Springer, Ph.D. (“Consultant”) by Morphic Rock Holding, LLC, f/k/a Integrin Rock, LLC (the “Company”), a Delaware limited liability company. For good and valuable consideration, the parties hereby agree as follows:
